Showing 2,121 - 2,140 results of 5,902 for search '(( significantly ((larger decrease) OR (linear decrease)) ) OR ( significantly higher decrease ))', query time: 0.44s Refine Results
  1. 2121
  2. 2122
  3. 2123
  4. 2124

    Raw data. by Guohui Zhao (4668682)

    Published 2025
    “…The control at 54lbs was significantly higher than at 60lbs (P<0.05). Deformation measurements were 18.53±4.90με, 16.31±4.42με, and 20.90±3.53με, with significantly lower deformation at 54lbs compared to 60lbs (P<0.05). …”
  5. 2125

    The participants information. by Guohui Zhao (4668682)

    Published 2025
    “…The control at 54lbs was significantly higher than at 60lbs (P<0.05). Deformation measurements were 18.53±4.90με, 16.31±4.42με, and 20.90±3.53με, with significantly lower deformation at 54lbs compared to 60lbs (P<0.05). …”
  6. 2126
  7. 2127
  8. 2128
  9. 2129

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

    Published 2025
    “…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …”
  10. 2130

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

    Published 2025
    “…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …”
  11. 2131

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

    Published 2025
    “…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …”
  12. 2132
  13. 2133
  14. 2134

    Raw data. by Changzhi Liu (518454)

    Published 2025
    “…</p><p>Conclusion</p><p>Higher levels of remnant cholesterol and a higher RC-to-cholesterol ratio were associated with a reduced risk of vertebral fractures, particularly in women.…”
  15. 2135

    Baseline characteristics of the subjects. by Changzhi Liu (518454)

    Published 2025
    “…</p><p>Conclusion</p><p>Higher levels of remnant cholesterol and a higher RC-to-cholesterol ratio were associated with a reduced risk of vertebral fractures, particularly in women.…”
  16. 2136
  17. 2137
  18. 2138
  19. 2139
  20. 2140